Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below 200-Day Moving Average of $7.61

Shares of Bavarian Nordic A/S (OTCMKTS:BVNRY) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $7.61 and traded as low as $7.35. Bavarian Nordic A/S shares last traded at $7.39, with a volume of 2,178 shares trading hands.

Bavarian Nordic A/S Price Performance

The business’s 50 day moving average is $7.70 and its 200-day moving average is $7.61. The company has a market cap of $1.73 billion, a PE ratio of 5.68 and a beta of 1.50.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last issued its quarterly earnings results on Wednesday, March 6th. The company reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.44 by $0.12. The company had revenue of $353.27 million during the quarter, compared to the consensus estimate of $340.71 million. Bavarian Nordic A/S had a net margin of 20.80% and a return on equity of 0.07%. As a group, sell-side analysts predict that Bavarian Nordic A/S will post 0.57 EPS for the current fiscal year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.